Pharmacological treatment of pathologic aggression in children

International Review of Psychiatry

Volumn 20, Issue 2, 2008, Pages 151-157

  Barzman, Drew H ^a   Findling, Robert L ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CENTRAL STIMULANT AGENT; HALOPERIDOL; LITHIUM; METHYLPHENIDATE; MOLINDONE; NEUROLEPTIC AGENT; OLANZAPINE; PLACEBO; QUETIAPINE; RISPERIDONE; THIORIDAZINE; VALPROATE SEMISODIUM;

AGGRESSION; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; CHILD; CLINICAL TRIAL; CONDUCT DISORDER; DISRUPTIVE BEHAVIOR; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG USE; EXTRAPYRAMIDAL SYMPTOM; HUMAN; PATHOLOGIC AGGRESSION; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SIDE EFFECT; WEIGHT GAIN;

AGGRESSION; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; HEALTH STATUS; HUMANS; LITHIUM CARBONATE; METHYLPHENIDATE; PRESCRIPTIONS, DRUG; RISPERIDONE; TIME FACTORS; VALPROIC ACID; VIOLENCE;

EID: 41749089619     PISSN: 09540261     EISSN: 13691627     Source Type: Journal    
DOI: 10.1080/09540260801887819     Document Type: Review

References (43)

1. Aman, M. G., De Smedt, G., Derivan, A., et al. (2002). Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. American Journal of Psychiatry, 159, 1337-1346.
2. Aman, M. G., Binder, C., & Turgay, A. (2004). Risperidone effects in the presentation/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ. Journal of Child and Adolescent Psychopharmacology, 14(2), 243-254.
3. Armenteros, J. L., Lewis, J. E., & Davalos, M. (2007). Risperidone augmentation for treatment-resistant aggression in attention-deficit/ hyperactivity disorder: A placebo-controlled pilot study. Journal of the American Academy of Child and Adolescent Psychiatry, 46(5), 558-565.
4. Buitelaar, J. K., van der Gaag, R. J., Cohen-Kettenis, P., et al. (2001). A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities. Journal of Clinical Psychiatry, 62, 239-248.
5. Campbell, M., Small, A. M., Green, W. H., et al. (1984). Behavioral efficacy of haloperidol and lithium carbonate. Archives of General Psychiatry, 41, 650-656.
6. Campbell, M., Gonzalez, N. M., & Silva, R. R. (1992). The pharmacological treatment of conduct disorders and rage outbursts. Psychiatric Clinics of North America, 15, 69-85.
7. Campbell, M., Adams, P. B., Small, A. M., et al. (1995). Lithium in hospitalized aggressive children with conduct disorder: Double blind and placebo controlled study. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 445-453.
8. Campbell, M., Armenteros, J. L., Malone, R. P., et al. (1997). Neuroleptic-related dyskinesia in autistic children: A prospective, longitudinal study. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 835-843.
9. Donovan, S. J., Stewart, J. W., Nunes, E. V., et al. (2000). Divalproex treatment for youth with explosive temper and mood lability: A double-blind, placebo-controlled crossover design. American Journal of Psychiatry, 157, 818-820.
10. Fergusson, D. M., Horwood, L. J., & Ridder, E. M. (2007). Conduct and attentional problems in childhood and adolescence and later substance use, abuse, and dependence: Results of a 25-year longitudinal study. Drug and Alcohol Dependence, 88 (Suppl. 1), S14-26.
11. Findling, R. L., McNamara, N. K., Branicky, L. A., et al. (2000). A double-blind pilot study of risperidone in the treatment of conduct disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 509-516.
12. Findling, R. L. (2003). Treatment of aggression in children. Journal of Clinical Psychiatry, 5(Suppl. 6), 5-9.
13. Findling, R. L., Kusumakar, V., Daneman, D., et al. (2003). Prolactin levels during long-term risperidone treatment in children and adolescents. Journal of Clinical Psychiatry, 64, 1362-1369.
14. Findling, R. L., Aman, M. G., Eerdekens, M., et al. (2004). Long-term, open-label study of risperidone in children with severe disruptive behaviors and below-average IQ. American Journal of Psychiatry, 161, 677-684.
15. Findling, R. L., & McNamara, N. K. (2004). A typical antipsychotics in the treatment of children and adolescents: Clinical applications. Journal of Clinical Psychiatry, 65(Suppl. 6), 30-44.
16. Findling, R., Blumer, J., Kauffman, R., et al. (2004). Pharmacokinetic effects of aripiprazole in children and adolescents with conduct disorder. International Journal of Neuropsychopharmacology, 7, S440.
17. Findling, R. L., Reed, M. D., O'Riordan, M. A., et al. (2006). Effectiveness, safety, and pharmacokinetics of quetiapine in aggressive children with conduct disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 792-800.
18. Findling, R. L., Reed, M. D., O'Riordan, M. A., et al. (2007). A 26-week open-label study of quetiapine in children with conduct disorder. Journal of Child and Adolescent Psychopharmacology, 17(1), 1-9.
19. Gillberg, C. (2000). Typical neuroleptics in child and adolescent psychiatry. European Child and Adolescent Psychiatry, 9(Suppl. 1), I/2-I/8.
20. Greenhill, L. L., Solomon, M., Pleak, R., et al. (1985). Molindone hydrochloride treatment of hospitalized children with conduct disorder. Journal of Clinical Psychiatry, 46, 20-25.
21. Jensen, P. S., Youngstrom, E. A., Steiner, H., Findling, R. L., et al. (2007). Consensus report on impulsive aggression as a symptom across diagnostic categories in child psychiatry: Implications for medication studies. Journal of the American Academy of Child and Adolescent Psychiatry, 46(3), 309-322.
22. Keenan, K., Wakschlag, L. S., Danis, B., et al. (2007). Further evidence of the reliability and validity of DSM-IV ODD and CD in preschool children. Journal of the American Academy of Child and Adolescent Psychiatry, 46(4), 467-468.
23. Kim-Cohen, J., Arseneault, L., Caspi, A., et al. (2005). Validity of DSM-IV conduct disorder in 41/2-5-year-old children: A longitudinal epidemiological study. American Journal of Psychiatry, 162, 1108-1117.
24. Klein, R. G., Abikoff, H., Klass, E., et al. (1997). Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder. Archives of General Psychiatry, 54, 1073-1080.
25. Malone, R. P., Delaney, M. A., Luebbert, J. F., et al. (2000). A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder. Archives of General Psychiatry, 57, 649-654.
26. Mesman, J., & Koot, H. M. (2001). Early preschool predictors of preadolescent internalizing and externalizing DSM-IV diagnoses. Journal of the American Academy of Child and Adolescent Psychiatry, 40(9), 1029-1036.
27. MTA Cooperative Group (1999). A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56, 1073-1086.
28. Pandina, G. J., Aman, M. G., & Findling, R. L. (2006). Risperidone in the management of disruptive behavior disorders. Journal of Child and Adolescent Psychopharmacology, 16, 379-392.
29. Pappadopulos, E., MacIntyre II, J. C., Crimson, M. L., et al. (2003). Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II. Journal of the American Academy of Child and Adolescent Psychiatry, 42(2), 145-161.
30. Patel, N. C., Sanchez, R. J., Johnsrud, M. T., & Crimson, M. L. (2002). Trends in antipsychotic use in a Texas Medicaid population of children and adolescents: 1996-2000. Journal of Child and Adolescent Psychopharmacology, 12, 1219-1242.
31. Patel, N. C., Crimson, M. L., Hoagwood, K, et al. (2005). Trends in the use of typical and atypical antipsychotics in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 44, 548-556.
32. Research Units on Pediatric Phychopharmacology Autism Network (2002). Risperidone in children with autism and serious behavioral problems. New England Journal of Medicine, 347, 314-321.
33. Reyes, M., Buitelaar, J., Toren, P., et al. (2006a). A randomized, double-blind, placebo-controlled study of risperidone maintenance treatment in children and adolescents with disruptive behavior disorders. American Journal of Psychiatry, 163, 402-410.
34. Reyes, M., Olah, R., Csaba, K., et al. (2006b). Long-term safety and efficacy of risperidone in children with disruptive behaviour disorders. Results of a 2-year extension study. European Child Adolescent Psychiatry, 15, 97-104.
35. Rifkin, A., Karajgi, B., Dicker, R., et al. (1997). Lithium treatment of conduct disorders in adolescents. American Journal of Psychiatry, 154, 554-555.
36. Satterfield, J. H., Faller, K. J., Crinella, F. M., et al. (2007). A 30-year prospective follow-up study of hyperactive boys with conduct problems: Adult criminality. Journal of American Academy of Child and Adolescent Psychiatry, 46, 601-610.
37. Schur, S. B., Sikich, L., Findling, R. L., et al. (2003). Treatment ecommendations for the use of antipsychotics for aggressive youth (TRAAY). I: A review. Journal of the American Academy of Child and Adolescent Psychiatry, 42(2), 132-144.
38. Scott, S. (1998). Aggressive behaviour in childhood. British Medical Journal, 316, 202-206.
39. Sikich, L., Hamer, R. M., Bashford, R. A., et al. (2004). A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: A double-blind, randomized, 8-week trial. Neuropsychopharmacaology, 29, 133-145.
40. Snyder, R., Turgay, A., Aman, M. G., et al. (2002). Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1026-1036.
41. Staller, J. A. (2007). Psychopharmacologic treatment of aggressive preschoolers: a chart review. Prog Neuropsychopharmacol Biol Psychiatry, 31, 131-135.
42. Van Bellinghen, M., & De Troch, C. (2001). Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: A double blind, placebo-controlled pilot trial. Journal of Child and Adolescent Psychopharmacology, 11, 4-13.
43. Zigler, E., Taussig, C., & Black, K. (1992). Early childhood intervention. A promising preventative for juvenile delinquency. American Psychologist, 47(8), 997-1006.